Pavilion Capital
Pavilion Capital is providing growth equity to market leading companies.
Business Model:
Revenue: $2M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Pavilion Capital Information
Geographic Data
Address: 270 Lafayette St
City: New York
State: NY
Zip: 10012
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
7,304,025Website Global Rank
542Website Monthly Traffic
Twitter Followers
Description
Pavilion Capital Partners is a growth-oriented private equity investor. It provides capital and strategic support to companies in the United States and Asia. In particular, the focus is on industries experiencing high growth due to globalization, technology, or demographic trends. It actively works with company founders/management to assist in strategic initiatives, mergers and acquisitions, and eventual liquidity. The pavilion is partnered with family offices and private equity funds and is based in New York City.
Contact Phone:
+12126758289
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2021 | OY! | Series A | 0 |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 11/2022 | JNPMEDI | Series A | 10.3M |
| 5/2021 | Inari | Series D | 0 |
| 4/2015 | TMON | Private Equity Round | 360M |
| 7/2020 | Sociolla | Series E | 58M |
| 8/2022 | Insilico Medicine | Series D | 35M |
| 4/2023 | Travelio | Series C | - |
| 3/2021 | Sicepat Express | Series B | 0 |
| 11/2019 | Cityneon | Private Equity Round | - |
| 11/2019 | Appier | Series D | 80M |
| 2/2020 | KAHR medical | Venture Round | 18M |
| 10/2021 | Accredify | Series A | 0 |
| 2/2020 | GudangAda | Seed Round | 10.5M |
| 11/2020 | Zilliz | Series B | 43M |
| 3/2021 | Duckbill | Venture Round | 0 |
| 6/2021 | KAHR medical | Venture Round | 0 |
| 6/2021 | SUPER STUDIO | Venture Round | 1.6M |
| 5/2019 | Schrödinger | Series E | 25M |
| 1/2019 | Warung Pintar | Series A | 0 |
| 8/2019 | Edmicro | Seed Round | - |
| 12/2018 | 17LIVE | Venture Round | 25M |
| 6/2016 | SORACOM | Series B | 28.6M |
| 9/2014 | STAR 360 | Private Equity Round | - |
| 6/2018 | Insilico Medicine | Series A | 6M |
| 5/2021 | NiKang Therapeutics | Series C | 200M |
| 10/2021 | Infinium | Venture Round | 0 |
| 1/2020 | OY! | Seed Round | - |
| 6/2021 | Standigm | Series D | 10M |
| 3/2022 | Synspective | Series B | 96.6M |
| 12/2021 | UrBox | Series A | - |
| 4/2021 | Touchstone Partners | Series A | 25M |
| 11/2021 | Linc&s;well | Series C | 69.5M |
| 3/2020 | Doctor Anywhere | Series B | 27M |
| 3/2022 | Ark Edge Space | Series A | 5.2M |
| 12/2022 | QuQo | Seed Round | 1M |
| 10/2019 | Structo | Series D | - |
| 7/2021 | Atama plus | Series B | 0 |
| 12/2021 | ROKT | Series E | 325M |
| 8/2018 | Warung Pintar | Seed Round | 0 |
| 1/2019 | Fore Coffee | Series A | 9.5M |
| 11/2019 | Travelio | Series B | 0 |
| 11/2021 | HEPMIL | Series A | 0 |
| 5/2022 | MOMA Therapeutics | Series B | 0 |
| 4/2022 | Swatch On | Venture Round | 10M |
| 12/2021 | Space BD | Venture Round | 9.2M |
| 9/2019 | Insilico Medicine | Series B | 37M |
| 9/2021 | Allay Therapeutics | Series C | 60M |
| 1/2020 | ReadCoor | Series B | 27M |
| 10/2022 | LevitasBio | Series C | 35M |
| 10/2019 | Nuvation Bio | Series A | 275M |
| 12/2018 | Airobotics | Series D | 40.3M |
| 3/2023 | Flare Therapeutics | Series B | 0 |
| 7/2021 | Pivot Bio | Series D | 0 |
| 4/2020 | Pivot Bio | Series C | 0 |
| 4/2021 | Studist | Venture Round | 17.1M |
| 12/2017 | Orchard Therapeutics | Series B | 0 |
| 11/2021 | HotSpot Therapeutics | Series C | 0 |
| 6/2021 | SUPER STUDIO | Funding Round | 1.6M |
| 9/2019 | Advance Intelligence Group | Series C | 80M |
| 6/2022 | Insilico Medicine | Series D | 0 |
| 8/2022 | Zilliz | Series B | 60M |
| 11/2022 | Vow | Series A | 0 |
| 5/2021 | Blind | Series C | 0 |
| 9/2021 | Hydrogenious Technologies | Venture Round | 0 |
| 9/2020 | waresix | Series B | 0 |
| 8/2019 | CyCraft | Series B | 5.7M |
| 4/2022 | RVAC Medicines | Series B | 140M |
| 9/2022 | Asuene | Series B | 17.5M |
| 4/2022 | ENSEM Therapeutics | Series A | 67M |
| 6/2021 | Insilico Medicine | Series C | 0 |
| 11/2016 | Appier | Series B | 19.5M |
| 6/2022 | Insilico Medicine | Series D | 0 |
| 5/2022 | MOMA Therapeutics | Series B | 0 |
| 4/2022 | RVAC Medicines | Series B | 0 |
| 4/2022 | Swatch On | Venture Round | 0 |
| 4/2022 | ENSEM Therapeutics | Series A | 0 |
| 3/2022 | Synspective | Series B | 0 |
| 3/2022 | Ark Edge Space | Series A | 0 |
| 12/2021 | ROKT | Series E | 0 |
| 12/2021 | UrBox | Series A | - |
| 12/2021 | Space BD | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
